Cancer centers racing to map patients' genes
Electric fans growl like airplanes taking off and banks of green lights wink in a basement at Mount Sinai's medical school, where a new $3 million supercomputer makes quick work of huge amounts of genetic and other biological information. Just a couple of miles away, a competitor, Weill Cornell Medical College and NewYork-Presbyterian Hospital/Weill Cornell hospital are building a $650 million research tower. Across the street is a newly completed $550 million tower housing labs for another competitor, Memorial Sloan-Kettering Cancer Center. Major academic medical centers in New York and around the country are spending and recruiting heavily in what has become an arms race within the war on cancer.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers
- 5 Digital Marketing Efforts Every Hospital Should Try
- 16 Medicare Advantage Plans Earn 5-Star Ratings
- The Drug Price Reform Debate
- Ebola: A Call for Designated Hospitals